ICN Pharmaceuticals Inc saidits board approved the purchase of up to three mln shares ofits outstanding common stock.    ICN also said it plans to buy up to 500,000 more shareseach of Viratek Inc &lt;VIRA> and SPI Pharmaceuticals Inc &lt;SPIP>.    ICN said the buyback plans were approved because the boardbelieved that at current prices the investment represented bythe ICN group itself is in the best interests of theshareholders of the company. Reuter&#3;